Anrukinzumab (Anti-IL-13)
Products
Description
Anrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.
Specifications
| Manufacturer Cat# | A2665 |
|---|---|
| Target | IL Receptor |